JOSEPH LACOB

CIK 1215490 · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$208.61M

Companies

4

Total Filings

72

Lifetime Open-Market Net

-$95.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALGN Director 1,180,016 $174.84 $206.31M -$95.85M 52 2026-05-22
NPCE Director 142,928 $15.64 $2.24M $0 11 2026-03-24
Orexigen Therapeutics, Inc. (OREX) Delisted Director 1,179,804 $0 5 2011-06-06
EHTH Director 31,786 $1.81 $57.5K $0 4 2007-11-09

Recent Filings · Page 5 of 8

72 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-11-15 ALGN Sell (S) −62,479 -$5.72M EDGAR
2016-05-19 ALGN Grant (A) $0 EDGAR
2016-05-16 ALGN Exer (M) +5,500 $0 EDGAR
2015-07-31 ALGN Sell (S) −20,000 -$1.26M EDGAR
2015-07-29 ALGN Sell (S) +50,000 $3.03M EDGAR
2015-05-14 ALGN Mixed +5,500 $0 EDGAR
2015-02-24 ALGN $0 EDGAR
2014-12-23 ALGN Gift (G) −3,607 $0 EDGAR
2013-08-12 ALGN Mixed -$195.6K EDGAR
2013-05-31 ALGN Sell (S) −49,998 -$1.81M EDGAR
Showing 4150 of 72
Page 5 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.